Erschienen in:
01.10.2014 | Breast Oncology
The Promise of Axillary Imaging in Individualized Surgical Management of Breast Cancer Patients: Another Step Forward
verfasst von:
Tina J. Hieken, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 11/2014
Einloggen, um Zugang zu erhalten
Excerpt
Breast surgical oncologists are to be commended for moving forward rapidly to embrace selective and individualized therapy for their patients. Eleven years after publication of the first report and 3 years after reporting results from the largest randomized controlled clinical trial of sentinel lymph node resection (SLNR) versus axillary lymph node dissection (ALND) for clinically node-negative breast cancer patients, SLNR is widely accepted as standard in this setting and endorsed by national and international guidelines.
1‐
4 Moving forward, there is considerable interest in further refining and individualizing management of the axilla for newly diagnosed breast cancer patients, especially for those patients with node-positive disease. We have become champions of further minimizing patient morbidity. Enhanced axillary imaging as an approach toward more accurate preoperative nodal staging is an area of active investigation. At one end of the spectrum, there are patients without nodal disease who might be spared axillary surgery altogether, and at the other, there is growing interest in distinguishing node-positive patients who might be managed appropriately with SLNR alone from those who will benefit from ALND, with or without adjuvant radiation. …
